Medicus Pharma Ltd. (MDCXW) stock
MDCXWNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as MDCX
$0.21+0.00 (0.00%)
Close on Oct 30, 2026Market cap $118.78MP/E –Yield –
Medicus Pharma net income
Net income is the profit left for shareholders after every expense, interest and tax.
Medicus Pharma's net income for the twelve months ending Jun 30, 2026 was -$56.66M. For fiscal 2025 it was -$47.28M.
Annual net income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$47.28M | – |
| FY2024 | Dec 31, 2024 | -$11.16M | – |
| FY2023 | Dec 31, 2023 | -$5.31M | – |
Quarterly net income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$11.62M | – |
| Q1 FY2026 | Mar 31, 2026 | -$9.04M | – |
| Q4 FY2025 | Dec 31, 2025 | -$15.07M | – |
| Q3 FY2025 | Sep 30, 2025 | -$20.94M | – |
| Q2 FY2025 | Jun 30, 2025 | -$6.18M | – |
| Q1 FY2025 | Mar 31, 2025 | -$5.10M | – |
| Q4 FY2024 | Dec 31, 2024 | -$3.54M | – |
| Q3 FY2024 | Sep 30, 2024 | -$2.28M | – |
| Q2 FY2024 | Jun 30, 2024 | -$3.63M | – |
| Q1 FY2024 | Mar 31, 2024 | -$1.71M | – |